Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) General Information

Description

Worldwide distribution rights of 2 specialty drugs. The rights allows production and sale of Buccastem, used for the treatment of nausea and vomiting, and Timodine, a anti-fungal and anti-bacterial skin cream used for treating inflamed and infected skin conditions.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Healthcare
Acquirer
Primary Office
  • 103 - 105 Bath Road
  • Slough SL1 3UH
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)‘s full profile, request access.

Request a free trial

Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Reckitt Benckiser (Worldwide Rights of Buccastem and Timodine Brands)‘s full profile, request access.

Request a free trial